These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 1589764)

  • 1. Oncogenic forms of p53 inhibit p53-regulated gene expression.
    Kern SE; Pietenpol JA; Thiagalingam S; Seymour A; Kinzler KW; Vogelstein B
    Science; 1992 May; 256(5058):827-30. PubMed ID: 1589764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p53: a transdominant regulator of transcription whose function is ablated by mutations occurring in human cancer.
    Unger T; Nau MM; Segal S; Minna JD
    EMBO J; 1992 Apr; 11(4):1383-90. PubMed ID: 1314165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A significant decrease of the transcriptional activity of p53 mutants deriving from human functional adrenal tumors.
    Lin SR; Yang YC; Jung JH; Tsai JH
    DNA Cell Biol; 1996 Oct; 15(10):793-803. PubMed ID: 8892752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stimulation of polyomavirus DNA replication by wild-type p53 through the DNA-binding site.
    Kanda T; Segawa K; Ohuchi N; Mori S; Ito Y
    Mol Cell Biol; 1994 Apr; 14(4):2651-63. PubMed ID: 8139565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overlap of the p53-responsive element and cAMP-responsive element in the enhancer of human T-cell leukemia virus type I.
    Aoyama N; Nagase T; Sawazaki T; Mizuguchi G; Nakagoshi H; Fujisawa JI; Yoshida M; Ishii S
    Proc Natl Acad Sci U S A; 1992 Jun; 89(12):5403-7. PubMed ID: 1535157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Wilms' tumor gene product WT1 activates or suppresses transcription through separate functional domains.
    Wang ZY; Qiu QQ; Deuel TF
    J Biol Chem; 1993 May; 268(13):9172-5. PubMed ID: 8486616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The tumor suppressor p53 regulates its own transcription.
    Deffie A; Wu H; Reinke V; Lozano G
    Mol Cell Biol; 1993 Jun; 13(6):3415-23. PubMed ID: 7684498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The core promoter region of the P-glycoprotein gene is sufficient to confer differential responsiveness to wild-type and mutant p53.
    Zastawny RL; Salvino R; Chen J; Benchimol S; Ling V
    Oncogene; 1993 Jun; 8(6):1529-35. PubMed ID: 8502478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of transcription functions of the p53 tumor suppressor by the mdm-2 oncogene.
    Chen J; Lin J; Levine AJ
    Mol Med; 1995 Jan; 1(2):142-52. PubMed ID: 8529093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cooperative DNA binding of p53 with TFIID (TBP): a possible mechanism for transcriptional activation.
    Chen X; Farmer G; Zhu H; Prywes R; Prives C
    Genes Dev; 1993 Oct; 7(10):1837-49. PubMed ID: 8405994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exogenous wt-p53 protein is active in transformed cells but not in their non-transformed counterparts: implications for cancer gene therapy without tumor targeting.
    D'Orazi G; Marchetti A; Crescenzi M; Coen S; Sacchi A; Soddu S
    J Gene Med; 2000; 2(1):11-21. PubMed ID: 10765501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mammalian p53 can function as a transcription factor in yeast.
    Schärer E; Iggo R
    Nucleic Acids Res; 1992 Apr; 20(7):1539-45. PubMed ID: 1579447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of the two-hybrid system to identify the domain of p53 involved in oligomerization.
    Iwabuchi K; Li B; Bartel P; Fields S
    Oncogene; 1993 Jun; 8(6):1693-6. PubMed ID: 8502489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Negative regulation of Rb expression by the p53 gene product.
    Shiio Y; Yamamoto T; Yamaguchi N
    Proc Natl Acad Sci U S A; 1992 Jun; 89(12):5206-10. PubMed ID: 1608930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel DNA binding of p53 mutants and their role in transcriptional activation.
    Zhang W; Funk WD; Wright WE; Shay JW; Deisseroth AB
    Oncogene; 1993 Sep; 8(9):2555-9. PubMed ID: 8361764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of partial loss of function p53 gene mutations utilizing a yeast-based functional assay.
    Kovvali GK; Mehta B; Epstein CB; Lutzker SG
    Nucleic Acids Res; 2001 Mar; 29(5):E28. PubMed ID: 11222779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physical and functional interaction between WT1 and p53 proteins.
    Maheswaran S; Park S; Bernard A; Morris JF; Rauscher FJ; Hill DE; Haber DA
    Proc Natl Acad Sci U S A; 1993 Jun; 90(11):5100-4. PubMed ID: 8389468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of p53 gene mutations in breast cancers and their effects on transcriptional activation function.
    Oh SJ; Jung JY; Shim SS; Im MY; Kim HD; Chung SY; Yoon JH
    Mol Cells; 2000 Jun; 10(3):275-80. PubMed ID: 10901165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptional activation of the human proliferating-cell nuclear antigen promoter by p53.
    Morris GF; Bischoff JR; Mathews MB
    Proc Natl Acad Sci U S A; 1996 Jan; 93(2):895-9. PubMed ID: 8570655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Gene product p53 is involved in the regulation of activity of the c-fos proto-oncogene promotor].
    Vikhanskaia FL; Pospelova TV; Volkov IV; Kukushkin AN; Svetlikova SB; Poslepov VA
    Dokl Akad Nauk SSSR; 1991; 321(4):846-9. PubMed ID: 1806357
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 21.